
Cancel anytime
- Chart
- Upturn Summary
- Highlights
Upturn AI SWOT - About
First Trust Bloomberg R&D Leaders ETF (RND)

- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/24/2025: RND (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Analysis of Past Performance
Type ETF | Historic Profit 29.81% | Avg. Invested days 112 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating ![]() | Upturn Advisory Performance | ETF Returns Performance |
Key Highlights
Volume (30-day avg) - | Beta - | 52 Weeks Range 19.84 - 26.69 | Updated Date 06/30/2025 |
52 Weeks Range 19.84 - 26.69 | Updated Date 06/30/2025 |
Upturn AI SWOT
First Trust Bloomberg R&D Leaders ETF
ETF Overview
Overview
The First Trust Bloomberg R&D Leaders ETF (EFIV) seeks to track the investment results of an index composed of U.S. companies that demonstrate leadership in research and development (R&D) spending. It targets the broad market with a focus on innovation and growth.
Reputation and Reliability
First Trust is a well-established ETF provider with a solid reputation for offering innovative investment solutions.
Management Expertise
First Trust has a team of experienced investment professionals dedicated to managing and monitoring their ETF offerings.
Investment Objective
Goal
The ETF aims to provide investment results that correspond generally to the price and yield of the Bloomberg U.S. Investment Grade Corporate Bond Index.
Investment Approach and Strategy
Strategy: The ETF tracks the Bloomberg U.S. R&D Leaders Index, which identifies companies with significant R&D spending.
Composition The ETF holds stocks of U.S. companies across various sectors, weighted based on their R&D expenditure.
Market Position
Market Share: EFIV's market share in the innovation-focused ETF space is moderate, competing with broader technology and growth ETFs.
Total Net Assets (AUM): 315840000
Competitors
Key Competitors
- ARK Innovation ETF (ARKK)
- SPDR S&P Biotech ETF (XBI)
- Invesco QQQ Trust (QQQ)
Competitive Landscape
The competitive landscape is dominated by larger, more established innovation and technology ETFs. EFIV distinguishes itself with its specific focus on R&D spending as a selection criterion. However, ARKK and QQQ are much larger and offer broader exposure, while XBI focuses on the biotechnology sector. EFIV offers more targeted approach to identifying innovative companies compared to broader growth ETFs but faces competition from sector-specific funds like XBI.
Financial Performance
Historical Performance: Historical performance data is available from financial data providers and should be reviewed for various time periods.
Benchmark Comparison: The ETF's performance should be compared to the Bloomberg U.S. R&D Leaders Index to assess its tracking effectiveness.
Expense Ratio: 0.0058
Liquidity
Average Trading Volume
The ETF's average daily trading volume is moderate, indicating reasonable liquidity.
Bid-Ask Spread
The bid-ask spread is typically tight, which helps minimize trading costs for investors.
Market Dynamics
Market Environment Factors
Economic indicators, technological advancements, and government policies related to R&D can impact the ETF's performance.
Growth Trajectory
The ETF's growth trajectory is tied to the performance of its underlying holdings and the overall health of the R&D-intensive sectors.
Moat and Competitive Advantages
Competitive Edge
EFIV's unique selection methodology based on R&D spending provides a distinct competitive advantage by focusing on companies committed to innovation. This focus allows investors to target firms that are actively investing in their future growth. The fund's weighting methodology also contributes to its distinct profile, potentially leading to different performance outcomes compared to broader tech or growth ETFs. First Trust's expertise in developing thematic ETFs further bolsters its competitive positioning in the market.
Risk Analysis
Volatility
The ETF's volatility is expected to be moderate to high, given its exposure to growth-oriented companies.
Market Risk
Market risk is a primary concern, as the ETF's performance is susceptible to overall market fluctuations and sector-specific downturns.
Investor Profile
Ideal Investor Profile
The ideal investor is someone seeking exposure to innovative companies and willing to accept moderate to high risk for potential long-term growth.
Market Risk
The ETF is best suited for long-term investors with a growth-oriented investment strategy.
Summary
The First Trust Bloomberg R&D Leaders ETF (EFIV) offers a targeted approach to investing in companies with high R&D spending. Its focus on innovation can provide growth potential, but also carries risks associated with technology and growth stocks. The ETF is well-suited for long-term investors seeking exposure to innovation. Investors should consider the fund's specific methodology and compare it to broader market and technology ETFs. Performance should be compared to the Bloomberg R&D Leaders Index to evaluate tracking effectiveness.
Peer Comparison
Sources and Disclaimers
Data Sources:
- First Trust
- Bloomberg
- Yahoo Finance
- ETFdb.com
- Morningstar
Disclaimers:
This data is for informational purposes only and should not be considered investment advice. Past performance is not indicative of future results. Consult with a qualified financial advisor before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About First Trust Bloomberg R&D Leaders ETF
Exchange NYSE ARCA | Headquaters - | ||
IPO Launch date - | CEO - | ||
Sector - | Industry - | Full time employees - | Website |
Full time employees - | Website | ||
Under normal market conditions, the fund will invest at least 80% of its net assets (plus any borrowings for investment purposes) in the securities that comprise the index. According to the index provider, the index is designed to track the performance of companies that seek to return implicit value to shareholders by reinvesting in their own growth. The fund is non-diversified.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
Home 

